These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3577667)

  • 1. Evaluation of the urinary tract in children with myelomeningocele.
    Petersen T; Jensen PB
    Acta Neurol Scand; 1987 Jan; 75(1):46-51. PubMed ID: 3577667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of urinary tract complications with myelomeningocele.
    Cass AS; Luxenberg M; Johnson CF; Gleich P
    Urology; 1985 Apr; 25(4):374-8. PubMed ID: 3984125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder compliance in meningomyelocele children.
    Ghoniem GM; Bloom DA; McGuire EJ; Stewart KL
    J Urol; 1989 Jun; 141(6):1404-6. PubMed ID: 2724439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tract complications in myelomeningocele patients.
    Cass AS
    J Urol; 1976 Jan; 115(1):102-4. PubMed ID: 1107599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder-sphincter dysfunction in myelomeningocele.
    van Gool JD; Dik P; de Jong TP
    Eur J Pediatr; 2001 Jul; 160(7):414-20. PubMed ID: 11475578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of intravesical and rectal pressures simultaneously with electromyography of anal sphincter in children with myelomeningocele.
    van Gool JD; de Ridder AL; Kuijten RH; Donckerwolcke RA; Tiddens HA
    Dev Med Child Neurol; 1976 Jun; 18(3):287-301. PubMed ID: 780175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphincter behaviour in myelomeningocele.
    Mundy AR; Shah PJ; Borzyskowski M; Saxton HM
    Br J Urol; 1985 Dec; 57(6):647-51. PubMed ID: 4084723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of back closure on detrusor function in neonates with myelomeningocele.
    Kroovand RL; Bell W; Hart LJ; Benfield KY
    J Urol; 1990 Aug; 144(2 Pt 2):423-5; discussion 443-4. PubMed ID: 2374215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Categorization of bladder dynamics and treatment after fetal myelomeningocele repair: first 50 cases prospectively assessed.
    Leal da Cruz M; Liguori R; Garrone G; Leslie B; Ottoni SL; Carvalheiro S; Moron AF; Ortiz V; Macedo A
    J Urol; 2015 May; 193(5 Suppl):1808-11. PubMed ID: 25817149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper and lower urinary tract evaluation of 104 patients with myelomeningocele without adequate urological management.
    Bruschini H; Almeida FG; Srougi M
    World J Urol; 2006 Jun; 24(2):224-8. PubMed ID: 16758253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromyography of the external anal sphincter muscle during urodynamic testing in children with meningomyelocele.
    Lissens M; Van de Walle JP; Vereecken R; Bruyninckx F; Rosselle N
    Acta Belg Med Phys; 1990; 13(4):167-73. PubMed ID: 2097857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures.
    Bloom DA; Knechtel JM; McGuire EJ
    J Urol; 1990 Aug; 144(2 Pt 2):430-3; discussion 443-4. PubMed ID: 2374216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urological evaluation of patients that had undergone in utero myelomeningocele closure: A prospective assessment at first presentation and early follow-up. Do their bladder benefit from it?
    Macedo A; Leal M; Rondon A; Ortiz V; Moron AF; Cavalheiro S
    Neurourol Urodyn; 2015 Jun; 34(5):461-4. PubMed ID: 24729268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postnatal bladder function in fetoscopic myelomeningocele repair patients.
    Huang GO; Belfort MA; Whitehead WE; Olutoye OO; Castillo J; Castillo H; Ostermaier KK; Koh CJ; Tu DD
    J Pediatr Rehabil Med; 2017 Dec; 10(3-4):327-333. PubMed ID: 29125525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
    Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study.
    Sidi AA; Dykstra DD; Gonzalez R
    J Urol; 1986 Jan; 135(1):90-3. PubMed ID: 3941475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
    Horst M; Weber DM; Bodmer C; Gobet R
    Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelomeningocele. Part III. Urologic considerations.
    Tanagho EA
    West J Med; 1974 Oct; 121(4):292-6. PubMed ID: 4608774
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of urodynamic evaluation in newborns with myelodysplasia.
    Bauer SB; Hallett M; Khoshbin S; Lebowitz RL; Winston KR; Gibson S; Colodny AH; Retik AB
    JAMA; 1984 Aug; 252(5):650-2. PubMed ID: 6737668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.